Kapetanovic IM[au] - Search Results

Year	Number of Results
1977	2
1979	2
1980	1
1981	4
1982	2
1983	2
1984	2
1985	1
1986	3
1987	2
1988	3
1990	3
1993	3
1995	3
1996	1
1997	1
1998	1
1999	1
2002	1
2004	3
2005	3
2006	5
2007	7
2008	6
2009	8
2010	6
2011	7
2012	7
2013	2
2022	0

1

Overview of commonly used bioinformatics methods and their applications.

Kapetanovic IM, Rosenfeld S, Izmirlian G. Kapetanovic IM, et al. Ann N Y Acad Sci. 2004 May;1020:10-21. doi: 10.1196/annals.1310.003. Ann N Y Acad Sci. 2004. PMID: 15208179 Review.

2

Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.

Kapetanovic IM. Kapetanovic IM. Chem Biol Interact. 2008 Jan 30;171(2):165-76. doi: 10.1016/j.cbi.2006.12.006. Epub 2006 Dec 16. Chem Biol Interact. 2008. PMID: 17229415 Free PMC article. Review.

3

Proceedings: the Applications of Bioinformatics in Cancer Detection Workshop.

Kapetanovic IM, Umar A, Khan J. Kapetanovic IM, et al. Ann N Y Acad Sci. 2004 May;1020:1-9. doi: 10.1196/annals.1310.002. Ann N Y Acad Sci. 2004. PMID: 15208178 Review.

4

Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity.

Parman T, Bunin DI, Ng HH, McDunn JE, Wulff JE, Wang A, Swezey R, Rasay L, Fairchild DG, Kapetanovic IM, Green CE. Parman T, et al. Among authors: kapetanovic im. Toxicol Sci. 2011 Dec;124(2):487-501. doi: 10.1093/toxsci/kfr238. Epub 2011 Sep 13. Toxicol Sci. 2011. PMID: 21920950 Free PMC article.

5

Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability.

Kapetanovic IM, Lyubimov AV, Kabirova EV, Kabirov KK, Rasay L, Swezey R, Green C, Kopelovich L. Kapetanovic IM, et al. Chem Biol Interact. 2012 Apr 15;197(1):16-22. doi: 10.1016/j.cbi.2012.03.002. Epub 2012 Mar 19. Chem Biol Interact. 2012. PMID: 22450444 Free PMC article.

6

Determination and stability of CP-31398 in plasma from experimental animals by LC-MS/MS.

Muzzio M, Huang Z, Johnson WD, McCormick DL, Kapetanovic IM. Muzzio M, et al. Among authors: kapetanovic im. J Pharm Biomed Anal. 2011 Dec 5;56(4):809-14. doi: 10.1016/j.jpba.2011.07.013. Epub 2011 Jul 22. J Pharm Biomed Anal. 2011. PMID: 21831553 Free PMC article.

7

Evaluation of chemopreventive agents for genotoxic activity.

Doppalapudi RS, Riccio ES, Rausch LL, Shimon JA, Lee PS, Mortelmans KE, Kapetanovic IM, Crowell JA, Mirsalis JC. Doppalapudi RS, et al. Among authors: kapetanovic im. Mutat Res. 2007 May 18;629(2):148-60. doi: 10.1016/j.mrgentox.2007.02.004. Epub 2007 Feb 25. Mutat Res. 2007. PMID: 17387038

8

Enhanced oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs.

Banerjee AA, Shen H, Hautman M, Anwer J, Hong S, Kapetanovic IM, Liu Y, Lyubimov AV. Banerjee AA, et al. Among authors: kapetanovic im. Curr Pharm Biotechnol. 2013;14(4):464-9. doi: 10.2174/1389201011314040012. Curr Pharm Biotechnol. 2013. PMID: 23590143

9

Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats.

Kapetanovic IM, Muzzio M, McCormick DL, Thompson TN, Johnson WD, Horn TL, Mohammed A, Rao CV, Kopelovich L. Kapetanovic IM, et al. Cancer Chemother Pharmacol. 2012 May;69(5):1301-6. doi: 10.1007/s00280-011-1811-9. Cancer Chemother Pharmacol. 2012. PMID: 22302406

10

Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen.

Doppalapudi RS, Riccio ES, Davis Z, Menda S, Wang A, Du N, Green C, Kopelovich L, Rao CV, Benbrook DM, Kapetanovic IM. Doppalapudi RS, et al. Among authors: kapetanovic im. Mutat Res. 2012 Jul 4;746(1):78-88. doi: 10.1016/j.mrgentox.2012.03.009. Epub 2012 Apr 10. Mutat Res. 2012. PMID: 22498038 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results